Private company
Immunomedics (United States)
Former pharmaceutical company
Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences for $21 billion.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industrybiotechnology1
- HeadquartersMorris Plains1
- Websiteimmunomedics.com
See how the biggest companies compare on our leaderboards
Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences for $21 billion.2
Corporate structure
Immunomedics (United States) sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- Immunomedics (United States) Morris Plains
- Immunomedics (Germany) Subsidiary ยท Germany
Built from subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
Subsidiaries and ownership
Subsidiaries
- Immunomedics (Germany)
From Wikidata.1
Timeline
- 1982Founded Founded1
Links
- Websitewww.immunomedics.com1
- Websiteimmunomedics.com1
- WikipediaImmunomedics
- WikidataQ30279582
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2